— Know what they know.
Not Investment Advice

DNTH NASDAQ

Dianthus Therapeutics, Inc.
1W: +5.0% 1M: -1.8% 3M: +80.8% YTD: +125.9% 1Y: +369.0% 3Y: +724.6% 5Y: -49.4%
$86.48
-3.15 (-3.51%)
After Hours: $91.19 (+4.71, +5.45%)
Weekly Expected Move ±5.1%
$77 $82 $86 $91 $95
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 50 · $3.6B mcap · 29M float · 3.25% daily turnover · Short 53% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
31.2 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -167.0%  ·  5Y Avg: 20.1%
Cost Advantage
38
Intangibles
41
Switching Cost
12
Network Effect
47
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. DNTH has No discernible competitive edge (31.2/100). The business operates without significant structural advantages. The primary source of advantage is Network Effects. Negative ROIC of -167.0% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$120
Low
$122
Avg Target
$125
High
Based on 2 analysts since May 5, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 9Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$117.60
Analysts10
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-11 Evercore ISI Gavin Clark-Gartner Initiated $120 +35.7% $88.45
2026-05-06 Raymond James $51 $125 +74 +42.3% $87.83
2026-04-08 Wolfe Research Andy Chen Initiated $98 +12.0% $87.48
2026-03-09 UBS Maury Raycroft $125 $98 -27 +23.7% $79.23
2026-03-09 Jefferies Maury Raycroft $51 $98 +47 +23.7% $79.23
2026-03-09 Robert W. Baird Initiated $132 +66.6% $79.23
2026-03-09 H.C. Wainwright Swayampakula Ramakanth Initiated $130 +64.1% $79.23
2026-03-09 Oppenheimer Trevor Allred $62 $145 +83 +79.3% $80.88
2026-03-09 Stifel Nicolaus Alex Thompson Initiated $120 +48.9% $80.60
2026-03-09 Truist Financial $63 $110 +47 +38.8% $79.23
2026-02-11 Wedbush Initiated $55 +10.7% $49.70
2026-01-29 UBS Initiated $125 +134.8% $53.23
2026-01-08 Truist Financial $56 $63 +7 +65.4% $38.09
2025-11-06 Oppenheimer Trevor Allred $52 $62 +10 +70.0% $36.46
2025-10-14 Truist Financial Danielle Brill Initiated $56 +62.7% $34.42
2025-09-08 Guggenheim Yatin Suneja Initiated $100 +215.2% $31.73
2025-09-08 Jefferies Maury Raycroft Initiated $51 +60.4% $31.80
2024-11-11 Oppenheimer Leland Gershell Initiated $52 +81.0% $28.73
2024-04-18 Raymond James Steven Seedhouse Initiated $51 +111.2% $24.15

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
4
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. DNTH receives an overall rating of C. Strongest factors: D/E (4/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-11 C- C
2026-04-01 C C-
2026-03-10 C- C
2026-03-09 C C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

38 Grade D
Profitability
20
Balance Sheet
85
Earnings Quality
35
Growth
48
Value
30
Momentum
50
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. DNTH scores highest in Safety (100/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
63.26
Safe Zone
Piotroski F-Score
2/9
Beneish M-Score
-2.99
Unlikely Manipulator
Ohlson O-Score
-3.81
Bankruptcy prob: 2.2%
Low Risk
Credit Rating
A+
Score: 75.6/100
Trend: Stable
Earnings Quality
OCF/NI: 11.51x
Accruals: 26.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. DNTH scores 63.26, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. DNTH scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. DNTH's score of -2.99 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. DNTH's implied 2.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. DNTH receives an estimated rating of A+ (score: 75.6/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-370.96x
PEG
-5477.42x
P/S
2732.75x
P/B
3.50x
P/FCF
-30.89x
P/OCF
EV/EBITDA
-19.36x
EV/Revenue
2715.57x
EV/EBIT
-19.32x
EV/FCF
-27.80x
Earnings Yield
-0.28%
FCF Yield
-3.24%
Shareholder Yield
0.01%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. DNTH currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.060
EBT / EBIT
×
EBIT Margin
-140.543
EBIT / Rev
×
Asset Turnover
0.003
Rev / Assets
×
Equity Multiplier
1.070
Assets / Equity
=
ROE
-2.7%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. DNTH's ROE of -2.7% is driven by Asset Turnover (0.003), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$86.48
Median 1Y
$50.24
5th Pctile
$12.30
95th Pctile
$208.77
Ann. Volatility
87.3%
Analyst Target
$117.60
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Marino Garcia
President and Chief Executive Officer
$630,000 $— $10,614,702
Simrat Randhawa, M.D.
Executive Vice President, Head of Research and Development
$530,555 $— $5,221,537
Ryan Savitz
Executive Vice President, Chief Financial Officer, Chief Business Officer and Treasurer
$482,560 $— $5,074,953

CEO Pay Ratio

30947:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $10,614,702
Avg Employee Cost (SGA/emp): $343
Employees: 100,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
100,000
+128105.1% YoY
Revenue / Employee
$20
Rev: $2,036,000
Profit / Employee
$-1,623
NI: $-162,337,000
SGA / Employee
$343
Avg labor cost proxy
R&D / Employee
$1,456
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -49.3% -49.1% -44.9% -48.4% -48.6% -42.5% -47.2% -34.3% -29.3% -35.0% -35.9% -41.4% -46.7% -55.3% -32.6% -38.6% -44.0% -48.5% 0.0% -2.7% -2.68%
ROA -43.5% -43.3% -40.5% -43.6% -43.8% -38.3% -42.6% -31.0% -26.5% -31.6% -33.2% -38.3% -43.2% -51.1% -30.7% -36.4% -41.5% -45.7% 0.0% -2.5% -2.50%
ROIC 11.8% 11.8% 13.9% 14.8% 14.9% 13.1% 46.0% 33.8% 29.0% 34.7% 8.9% 10.8% 12.7% 15.4% -1.0% -1.2% -1.3% -1.4% -1.6% -1.7% -1.67%
ROCE -46.8% -46.6% -39.7% -42.8% -43.0% -37.8% -78.2% -57.9% -52.2% -60.9% -28.5% -34.5% -39.9% -48.8% -28.6% -33.0% -36.5% -38.5% -34.9% -37.5% -37.54%
Gross Margin 1.0% 95.8% 1.0% 91.3% 97.9% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 83.6% 83.59%
Operating Margin -7.0% -9.1% -16.1% -12.2% -17.1% -28.4% -20.4% -11.9% -13.8% -24.1% -28.5% -181.0% -101.7% -244.9% -100.5% -100.50%
Net Margin -6.6% -8.6% -14.9% -11.5% -16.0% -23.1% -15.7% -9.5% -11.6% -21.4% -25.4% -163.9% -92.8% 344.7% -88.2% -88.19%
EBITDA Margin -7.0% -8.6% -16.1% -13.4% -16.0% -28.1% -20.3% -11.9% -13.7% -24.0% -28.4% -180.5% -92.8% -244.0% -100.5% -100.50%
FCF Margin -30.7% -12.4% -7.0% -2.0% -6.3% -8.9% -9.3% -9.7% -11.7% -12.6% -13.9% -20.7% -35.6% -63.5% -97.7% -97.67%
OCF Margin -30.6% -12.4% -6.9% -2.0% -6.3% -9.0% -9.3% -9.7% -11.7% -12.5% -13.9% -20.6% -35.6% -63.4% -97.5% -97.52%
ROE 3Y Avg snapshot only -20.20%
ROE 5Y Avg snapshot only -32.47%
ROA 3Y Avg snapshot only -19.02%
ROIC Economic snapshot only -30.54%
Cash ROA snapshot only -24.54%
Cash ROIC snapshot only -1.44%
CROIC snapshot only -1.44%
NOPAT Margin snapshot only -113.11%
Pretax Margin snapshot only -8.48%
R&D / Revenue snapshot only 114.64%
SGA / Revenue snapshot only 29.54%
SBC / Revenue snapshot only 21.02%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -7.48 -6.09 -3.66 -2.23 -0.92 -1.24 -0.41 -1.14 -1.27 -1.24 -1.08 -15.33 -15.63 -13.97 -8.99 -6.45 -5.82 -11.77 -355.99 -370.959
P/S Ratio 71.25 10.20 17.07 12.12 15.07 16.67 238.82 215.10 174.69 122.49 99.52 137.49 483.17 764.98 3017.15 2732.753
P/B Ratio 3.65 2.96 1.51 0.99 0.41 0.48 0.33 0.65 0.62 0.73 0.28 4.56 5.25 5.55 2.17 1.84 1.89 4.22 3.16 8.17 3.496
P/FCF -9.01 -7.22 -4.28 -2.67 -1.04 -2.32 -0.82 -2.44 -6.12 -2.40 -1.86 -25.71 -22.29 -14.96 -9.76 -7.14 -6.65 -13.57 -12.05 -30.89 -30.892
P/OCF
EV/EBITDA -5.51 -4.08 -1.21 0.09 1.45 1.44 0.90 0.63 0.74 0.47 2.61 -10.24 -10.57 -9.27 -4.83 -3.22 -3.04 -8.89 -6.64 -19.36 -19.362
EV/Revenue -79.59 -21.61 -9.38 -7.57 -6.01 -44.59 185.12 173.06 142.43 78.59 57.56 81.09 394.23 567.09 2715.57 2715.568
EV/EBIT -5.36 -3.97 -1.17 0.08 1.38 1.38 0.87 0.61 0.73 0.47 2.60 -10.18 -10.52 -9.22 -4.81 -3.20 -3.03 -8.87 -6.62 -19.32 -19.322
EV/FCF -6.46 -4.70 -1.37 0.10 1.57 2.59 1.74 1.34 3.82 0.96 4.99 -19.93 -17.93 -12.19 -6.26 -4.13 -3.92 -11.07 -8.93 -27.80 -27.804
Earnings Yield -13.4% -16.4% -27.3% -44.9% -1.1% -80.5% -2.4% -87.7% -78.6% -80.7% -92.4% -6.5% -6.4% -7.2% -11.1% -15.5% -17.2% -8.5% 0.0% -0.3% -0.28%
FCF Yield -11.1% -13.8% -23.3% -37.4% -95.9% -43.1% -1.2% -40.9% -16.3% -41.7% -53.6% -3.9% -4.5% -6.7% -10.3% -14.0% -15.0% -7.4% -8.3% -3.2% -3.24%
Price/Tangible Book snapshot only 8.170
EV/Gross Profit snapshot only 2879.364
Shareholder Yield snapshot only 0.01%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 13.26 13.26 16.63 16.63 16.63 16.63 9.97 9.97 9.97 9.97 18.42 18.42 18.42 18.42 15.22 15.22 15.22 15.22 13.32 13.32 13.323
Quick Ratio 13.26 13.26 16.63 16.63 16.63 16.63 9.97 9.97 9.97 9.97 18.42 18.42 18.42 18.42 15.22 15.22 15.22 15.22 13.32 13.32 13.323
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.003
Net Debt/Equity -1.03 -1.03 -1.02 -1.02 -1.02 -1.02 -1.01 -1.01 -1.01 -1.01 -1.03 -1.03 -1.03 -1.03 -0.78 -0.78 -0.78 -0.78 -0.82 -0.82 -0.817
Debt/Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.003
Debt/EBITDA -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.01 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.007
Net Debt/EBITDA 2.18 2.19 2.56 2.40 2.41 2.73 1.33 1.78 1.92 1.64 3.59 2.97 2.57 2.10 2.70 2.34 2.11 2.01 2.32 2.15 2.150
Interest Coverage -25.02 -33.26 -58.89 -94.75 -83.46 -72.16 -53.35
Equity Multiplier 1.12 1.12 1.10 1.10 1.10 1.10 1.13 1.13 1.13 1.13 1.06 1.06 1.06 1.06 1.06 1.06 1.06 1.06 1.08 1.08 1.076
Cash Ratio snapshot only 13.156
Cash to Debt snapshot only 291.699
FCF to Debt snapshot only -94.145
Defensive Interval snapshot only 766.6 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.02 0.03 0.03 0.02 0.02 0.03 0.04 0.02 0.02 0.02 0.01 0.00 0.00 0.003
Inventory Turnover
Receivables Turnover 0.83 1.00 1.35 1.26 0.92 1.05 1.35 1.75 9.70 10.15 7.55 4.79 4.48 2.94 2.939
Payables Turnover 0.15 0.31 0.45 0.81 1.02 0.86 1.17 0.59 0.06 0.07 0.05 0.05 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.011
DSO 0 438 364 271 290 395 346 271 208 38 36 48 76 81 124 124.2 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 2504 1186 803 450 357 422 313 617 5773 5051 6692 6692 36279 34348 34348.4 days
Cash Conversion Cycle -422 125 -252 -5501 -4761 -6297 -6346 -36008 -34224 -34224.3 days
Fixed Asset Turnover snapshot only 0.818
Cash Velocity snapshot only 0.003
Capital Intensity snapshot only 397.397
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 2.0% 20.4% 14.2% 8.6% 51.4% 1.2% 1.0% 17.9% -42.6% -67.3% -79.5% -79.52%
Net Income 15.7% 12.5% 5.1% -5.8% -9.5% 3.9% 18.3% 44.8% 53.0% 35.9% 25.1% -18.8% -56.9% -55.6% -95.1% -1.0% -1.0% -88.3% 1.0% 88.8% 88.76%
EPS 37.8% 27.9% 21.6% 12.6% 0.0% 5.0% 20.8% 46.5% 54.5% 39.3% 37.3% 82.5% 82.6% 82.2% 74.8% -43.9% -93.4% -70.6% 1.0% 91.6% 91.62%
FCF 8.7% 10.9% 5.6% 1.0% -16.1% 39.0% 52.0% 69.1% 88.9% 38.1% 13.5% -51.7% -4.3% -1.8% -2.1% -2.0% -1.5% -74.9% -65.1% -43.4% -43.44%
EBITDA 16.0% 12.8% 5.3% -4.8% -7.5% 4.7% 18.8% 43.0% 47.0% 29.9% 14.1% -38.6% -73.1% -81.4% -1.1% -1.0% -92.1% -65.5% -71.4% -60.5% -60.49%
Op. Income 16.7% 12.6% 5.1% -4.8% -8.9% 4.5% 18.5% 44.0% 52.2% 34.7% 20.8% -30.5% -79.0% -80.6% -1.1% -1.0% -88.9% -69.2% -74.7% -63.2% -63.22%
OCF Growth snapshot only -43.38%
Asset Growth snapshot only 41.95%
Equity Growth snapshot only 39.98%
Debt Growth snapshot only -7.04%
Shares Change snapshot only 34.20%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 37.9% -4.6% -22.1% -22.08%
Revenue 5Y
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y -7.2% -7.25%
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 43.7% 43.7% 6.5% 6.5% 6.5% 6.5% -19.9% -19.9% -19.9% -19.9% 3.5% 3.5% 3.5% 3.5% 25.3% 25.3% 25.3% 25.3% 85.5% 85.5% 85.55%
Assets 5Y 8.8% 8.8% 2.7% 2.7% 2.7% 2.7% 18.3% 18.3% 18.3% 18.3% 26.9% 26.9% 26.86%
Equity 3Y 41.9% 41.9% 5.8% 5.8% 5.8% 5.8% -19.5% -19.5% -19.5% -19.5% 5.5% 5.5% 5.5% 5.5% 26.9% 26.9% 26.9% 26.9% 88.5% 88.5% 88.51%
Book Value 3Y 22.1% 17.2% -12.5% -12.3% -9.6% -8.1% -30.5% -30.3% -30.2% -26.2% -7.7% -48.2% -51.4% -49.9% -40.2% -40.6% -40.6% -41.5% -12.4% -19.1% -19.14%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 1.00 1.00 1.00 1.00 1.00 0.60 0.60 0.60 0.41 0.60 0.68 0.67 0.66 0.80 0.79 0.81 0.81 0.65 0.38 0.24 0.236
Earnings Stability 0.63 0.57 0.44 0.29 0.56 0.37 0.05 0.19 0.07 0.02 0.07 0.34 0.32 0.31 0.06 0.00 0.02 0.15 0.37 0.15 0.149
Margin Stability 0.00 0.07 0.71 0.98 0.00 0.29 0.76 0.761
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.50 0.50 1.00 0.00 0.00 1.00 1.00 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.94 0.95 0.98 0.98 0.96 0.98 0.93 0.82 0.50 0.86 0.90 0.92 0.50 0.50 0.50 0.50 0.50 0.50 0.20 0.50 0.500
Earnings Smoothness
ROE Trend 0.03 0.04 0.12 0.10 0.09 0.14 -0.32 -0.10 -0.02 -0.15 0.34 0.21 0.13 0.09 0.28 0.15 0.09 0.13 0.25 0.27 0.269
Gross Margin Trend 1.28 0.54 0.24 0.02 0.02 0.02 -0.04 -0.041
FCF Margin Trend 6.82 -1.86 -5.80 -14.86 -26.63 -52.74 -86.05 -86.052
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.82 0.82 0.84 0.82 0.86 0.53 0.50 0.46 0.21 0.52 0.58 0.60 0.70 0.93 0.92 0.90 0.87 0.87 11.51 11.506
FCF/OCF 1.01 1.03 1.02 1.02 1.02 1.00 1.00 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.002
FCF/Net Income snapshot only 11.524
CapEx/Revenue 10.7% 5.9% 4.5% 0.5% 2.3% 3.5% 2.5% 2.1% 1.6% 1.7% 1.5% 2.6% 3.4% 10.5% 14.9% 14.90%
CapEx/Depreciation snapshot only 0.432
Accruals Ratio -0.08 -0.08 -0.07 -0.08 -0.06 -0.18 -0.21 -0.17 -0.21 -0.15 -0.14 -0.15 -0.13 -0.03 -0.02 -0.04 -0.05 -0.06 0.29 0.26 0.263
Sloan Accruals snapshot only 0.256
Cash Flow Adequacy snapshot only -654.704
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.01%
Net Buyback Yield -17.2% -21.3% -34.4% -52.3% -0.5% -1.2% -4.0% -2.0% -2.1% -1.3% -1.5% -39.2% -58.4% -47.5% -63.5% -39.3% -6.0% -21.1% 0.0% -18.3% -18.33%
Total Shareholder Return -17.2% -21.3% -34.4% -52.3% -0.5% -1.2% -4.0% -2.0% -2.1% -1.3% -1.5% -39.2% -58.4% -47.5% -63.5% -39.3% -6.0% -21.1% 0.0% -18.3% -18.33%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.00 0.99 0.99 0.98 0.92 0.94 0.90 0.86 0.84 0.81 0.83 0.86 0.88 0.92 -0.00 0.06 0.060
EBIT Margin -57.77 -24.95 -15.34 -10.31 -12.87 -17.15 -18.18 -16.46 -15.45 -16.34 -17.96 -26.77 -44.44 -85.66 -140.54 -140.543
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.02 0.03 0.03 0.02 0.02 0.03 0.04 0.02 0.02 0.02 0.01 0.00 0.00 0.003
Equity Multiplier 1.13 1.13 1.11 1.11 1.11 1.11 1.11 1.11 1.11 1.11 1.08 1.08 1.08 1.08 1.06 1.06 1.06 1.06 1.07 1.07 1.070
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-20.93 $-19.12 $-19.36 $-20.84 $-20.93 $-18.17 $-15.34 $-11.15 $-9.53 $-11.03 $-9.61 $-1.96 $-1.66 $-1.96 $-2.43 $-2.81 $-3.20 $-3.34 $0.00 $-0.24 $-0.24
Book Value/Share $42.87 $39.30 $47.00 $46.99 $46.97 $46.61 $19.43 $19.43 $19.43 $18.85 $37.28 $6.58 $4.93 $4.93 $10.06 $9.85 $9.84 $9.33 $13.05 $10.27 $25.01
Tangible Book/Share $42.87 $39.30 $47.00 $46.99 $46.97 $46.61 $19.43 $19.43 $19.43 $18.85 $37.28 $6.58 $4.93 $4.93 $10.06 $9.85 $9.84 $9.33 $13.05 $10.27 $10.27
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.32 $0.62 $0.75 $1.00 $0.91 $0.62 $0.13 $0.12 $0.16 $0.18 $0.18 $0.14 $0.08 $0.05 $0.03 $0.03
FCF/Share $-17.36 $-16.12 $-16.55 $-17.36 $-18.40 $-9.73 $-7.71 $-5.21 $-1.98 $-5.70 $-5.58 $-1.17 $-1.16 $-1.83 $-2.23 $-2.54 $-2.80 $-2.90 $-3.42 $-2.72 $-2.72
OCF/Share $-17.26 $-15.72 $-16.20 $-17.01 $-18.05 $-9.69 $-7.67 $-5.17 $-1.98 $-5.73 $-5.60 $-1.17 $-1.16 $-1.83 $-2.23 $-2.54 $-2.80 $-2.90 $-3.41 $-2.71 $-2.71
Cash/Share $44.34 $40.65 $48.15 $48.14 $48.13 $47.76 $19.92 $19.92 $19.91 $19.32 $38.35 $6.77 $5.08 $5.07 $7.86 $7.69 $7.68 $7.28 $10.70 $8.42 $23.14
EBITDA/Share $-20.35 $-18.58 $-18.81 $-20.09 $-19.99 $-17.50 $-14.81 $-11.10 $-10.28 $-11.63 $-10.65 $-2.27 $-1.97 $-2.41 $-2.90 $-3.26 $-3.61 $-3.61 $-4.60 $-3.90 $-3.90
Debt/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.21 $0.21 $0.21 $0.20 $0.13 $0.02 $0.02 $0.02 $0.04 $0.04 $0.04 $0.04 $0.04 $0.03 $0.03
Net Debt/Share $-44.34 $-40.65 $-48.15 $-48.14 $-48.13 $-47.76 $-19.71 $-19.71 $-19.71 $-19.12 $-38.22 $-6.75 $-5.06 $-5.06 $-7.81 $-7.65 $-7.64 $-7.24 $-10.66 $-8.39 $-8.39
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 63.262
Altman Z-Prime snapshot only 113.037
Piotroski F-Score 3 3 3 3 2 4 2 3 3 3 5 4 5 5 3 3 2 2 2 2 2
Beneish M-Score -5.28 -3.54 -1.64 -1.52 -0.62 13.94 13.05 23.44 18.27 -3.35 -2.99 -2.989
Ohlson O-Score snapshot only -3.811
ROIC (Greenblatt) snapshot only -49.37%
Net-Net WC snapshot only $7.74
EVA snapshot only $-160167510.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A+
Credit Score 67.88 67.63 68.08 87.30 36.59 41.64 33.55 43.41 53.85 59.73 60.06 76.44 76.56 76.30 76.29 76.25 76.42 76.04 76.15 75.61 75.608
Credit Grade snapshot only 5
Credit Trend snapshot only -0.641
Implied Spread (bps) snapshot only 125.000
Industry Credit Rank snapshot only 76
Sector Credit Rank snapshot only 70

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms